Joint Hospital Surgical Grand Round Radiofrequency Ablation of Hepatic Tumor (Factors affect local recurrence rate) Dr K Y Yuen United Christian Hospital.

Slides:



Advertisements
Similar presentations
Staging Strategy and Treatment for Patients With HCC
Advertisements

Great Debates & Updates in GI Malignancies
Hepatic Adenoma – Can we do more? Joint Hospital Grand Round
Joint Hospital Surgical Grand Round Carmen C.W. Chu Department of Surgery, Pamela Youde Nethersole Eastern Hospital.
Borderline Resectable Pancreatic Carcinoma
Radiotherapeutic Option in Management of Hepatocellular Carcinoma
Long term follow-up after pulmonary radiofrequency ablation T. de Baère, Institut Gustave Roussy - Villejuif - France.
Joint Hospital Surgical Grand Round. Fifth most common cancer in gastrointestinal tract More frequent in women Age standardized incidence rate ~3/100,000.
High Intensity Focused Ultrasound (HIFU) for Liver Tumour Dr Dai Wing Chiu Queen Mary Hospital.
High-Intensity Focused Ultrasound for Hepatocellular Carcinoma Joint Hospital Surgical Grand Round Queen Mary Hospital 19/10/2013.
Current Evidence in Ablative Therapy for Hepatocellular Carcinoma Joint Hospital Surgical Grand Round Dr Chu Ka Wan Queen Mary Hospital.
Management of colorectal cancer with liver metastasis Dr. Vivian Lee Department of Surgery, UCH.
Interventional Oncology Michael Kotton MD October 27, 2012.
Local Ablative Therapy for Hepatocellular Carcinoma
Joint Hospital Surgical Grand Round 16th Jan 2010 Dr James Fung Department of Surgery United Christian Hospital.
IMAGE-GUIDED ABLATION OF RENAL TUMORS
Radiofrequency Ablation of Lung Cancer
Management of Colorectal Liver Metastasis
Materials & Methods Prospective study in tertiary oncology centre. PJ used in 15 laparotomies and 6 laparoscopic debulking. Patient demographics, intra.
Living Longer: Colon Cancer Patients Gain Time With Radiofrequency Ablation Treatment CT Sofocleous, EN Petre, M Gonen, KT Brown, RH Thornton, AM Covey,
Liver Metastases Jean-Bernard Poulard MD, MBA, FACS Mount Sinai School of Medicine Queens Hospital Center Jamaica, NY.
Hepatocellular Carcinoma Detection and Treatment
Liver surgery AnatomyHepatectomy Liver tumors BenignMalignant.
DOWNSTAGING LOCALLY ADVANCED PANCREATIC ADENOCARCINOMA (LAPC) WITH VASCULAR ENCASEMENT USING PERCUTANEOUS IRREVERSIBLE ELECTROPORATION (IRE) NARAYANAN,GOVINDARAJAN;
Sorveglianza attiva e trattamenti mini-invasivi Vincenzo Ficarra Dipartimento di Scienze Sperimentali Mediche e Cliniche – Clinica di Urologia, Università.
Radiofrequency ablation of lung tumours Michelle Muller Consultant Radiologist Freeman Hospital.
Dr SH Chok Department of Surgery Ruttonjee & Tang Shiu Kin Hospitals
Management of early rectal carcinoma Joint Hospital Surgical Grand Round Jeren Lim United Christian Hospital.
Joint Hospital Surgical Grand Round 21 st July, 2012 RH.
Treatment Planning Optimization for Radiofrequency Ablation of Hepatic Tumors Hernán Abeledo, Ph.D. Associate Professor Engineering Management and Systems.
A REVISIT TO MANAGEMENT OF GASTROINTESTINAL STROMAL TUMOUR (GIST) Joint Hospital Surgical Grand Round 17 Jan 2015 Grace Liu Pamela Youde Nethersole Eastern.
June 6-10, 2004CRI Workshop, Haifa Treatment Planning for Radiofrequency Ablation of Liver Tumors Ariela Sofer, George Mason University Masami Stahr, George.
RFA Experience In Nicosia General Hospital (CLM) P. Hadjicostas,,M.Dietis, C. Antreou / Surgical Department.
Tumor Localization Techniques Richard Kao April 10, 2001 Computer Integrated Surgery II.
Joint Hospital Grand Round 20 th May 2006 Catherine Choi United Christian Hospital.
MANAGEMENT OF LUNG TUMORS; IMAGE-GUIDED ABLATION vs. SBRT
HEPATOCELLULAR CARCINOMA Monton. HCC in Thailand Most common cancer in Thai male Incidence 5 x 100,000 / year Male : female = 3-8:1 Age > 40 yr.
Guzman, Alexander Joseph Hipolito, April Lorraine
ACRIN 6673 Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma in Cirrhotic Patients: A Multi-Center Study.
In the name of Alla. Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta-analysis.
Pre-op Portal Vein Embolization for Major Hepatectomy SL Sin.
Hamid Tavakkoli, MD Associate Prof. of Gastroenterology.
Sorveglianza attiva e trattamenti ablativi Vincenzo Ficarra Direttore Clinica di Urologia Azienda Ospedaliera Universitaria di Udine.
SYNCHRONOUS COLORECTAL AND LIVER RESECTION J Peter A Lodge MD FRCS HPB and Transplant Unit St James’s University Hospital Leeds LS9 7TF 2006 Association.
Multicenter Study of Down-staging of Hepatocellular Carcinoma (HCC) to within Milan Criteria before Liver Transplantation Neil Mehta, MD; Jennifer Guy,
Ischemic bile duct injury as a serious complication after TACE in patients with HCC Kim, Hae Kyung Korea Kim, Hae Kyung Korea J Clinical Gastroenterology.
Anthropomorphic Liver Phantom for CT and Ultrasound Katelyn Herbert Advisor: Dr. Robert Galloway (BME) Department of Biomedical Engineering, Vanderbilt.
Pancreatic cancer.
Hepatocellular carcinoma related to Hbv and Hcv
Hamid Tavakkoli, MD Associate Prof. of Gastroenterology.
R3 정상완. Introduction  EGC : Tumor invasion is limited to the mucosa or submucosa, regardless of lymph node involvement.  Accumulated histopathological.
Treatment Strategy for Recurrent Hepatocellular Carcinoma: Salvage Transplantation, Repeated Resection, or Radiofrequency Ablation? Albert C. Y. Chan,
Management of Hepatocellular carcinoma
Gallbladder Cancer Surgical Management
Treatment of Colorectal Cancer Metastases to the Liver David U. Kim, MD University of Wisconsin School of Medicine and Public Health Department of Radiology.
© 2016 Global Market Insights, Inc. USA. All Rights Reserved Fuel Cell Market size worth $25.5bn by 2024Low Power Wide Area Network.
Microwave Ablation of Bilateral Adrenal Metastases
Dustin Thompson, MD Associate Staff  |  Interventional Radiology
PANCREATODUODENECTOMY + MULTIVISCERAL RESECTION YES/NO
Liver Cancer.
Hepatocellular Carcinoma: Diagnosis and Management
Rapid on-site evaluation may optimize patient selection for radio-frequency-ablation therapy Dr Wolfgang Pokieser Pathologisch-bakteriologisches Institut.
MANAGEMENT OF SMALL RENAL TUMORS: Current Evidence
Percutaneous Cryoablation of Metastatic Ovarian Cancer for Local Tumor Control: Improved Patient Survival and Estimated Cost-Effectiveness Brandt P. Currier.
SPECIMEN SONOGRAM - Procedure
Locally-Advanced HCC:
高雄長庚 大腸直腸外科 吳昆霖 盧建璋, 陳鴻華, 李克釗, 胡萬祥, 張家駱, 蔡鎧隆, 林岳民, 鄭功全
Volume 68, Issue 4, Pages (April 2018)
Retrospective Review of Efficacy of Radiofrequency Ablation for Treatment of Colorectal Cancer Liver Metastases From a Canadian Perspective  Benjamin.
Bile duct invasion itself can be the prognosis factor in early HCC
Presentation transcript:

Joint Hospital Surgical Grand Round Radiofrequency Ablation of Hepatic Tumor (Factors affect local recurrence rate) Dr K Y Yuen United Christian Hospital

Introduction Hepatocellular carcinoma (HCC) is the fifth most common malignancy in the world Hepatocellular carcinoma (HCC) is the fifth most common malignancy in the world Global annual incidence is one million new patients Global annual incidence is one million new patients 70% in Asia and 12% in Africa 70% in Asia and 12% in Africa

Introduction Surgery is the only known curative option for either primary or secondary hepatic carcinoma Surgery is the only known curative option for either primary or secondary hepatic carcinoma Resection or transplantation is the gold standard of treatment for liver tumor Resection or transplantation is the gold standard of treatment for liver tumor Only 20% to 37% of patients is suitable for hepatectomy Only 20% to 37% of patients is suitable for hepatectomy Fan et la, Annals of Surgery 1999

Introduction Factors limit the surgical intervention: multiple / diffuse tumors multiple / diffuse tumors tumor in unresectable locations (proximity of the tumors to major vascular and biliary structures) tumor in unresectable locations (proximity of the tumors to major vascular and biliary structures) Poor co-morbidity Poor co-morbidity inadequate liver reserve inadequate liver reserve significant portal hypertension significant portal hypertension 5- year survival rate for resectable HCC or liver metastasis is only % Loco-regional therapies have been developed for the treatment of unresectable liver tumor

Nguyen et la, Clinical Gastroenterology 2005

Radio Frequency Ablation First described by Rossi et al in 1993 First described by Rossi et al in 1993 High-frequency ( KHz) alternating RF current causes oscillatory movement of ions in tissue High-frequency ( KHz) alternating RF current causes oscillatory movement of ions in tissue The mechanism of tissue heating is frictional heat caused by the motion from the ionic current The mechanism of tissue heating is frictional heat caused by the motion from the ionic current Cause coagulation necrosis at temperature between o C Cause coagulation necrosis at temperature between o C

Radio Frequency Ablation Indications: Alterative to surgery in poor liver function patient with primary or secondary liver tumor Alterative to surgery in poor liver function patient with primary or secondary liver tumor Supplementary to surgery in bilobal tumors Supplementary to surgery in bilobal tumors Liver transplant candidates (bridge) Liver transplant candidates (bridge) Some transplant surgeons are using percutaneous or laparoscopic RFA to treat HCCs detected in patients with cirrhosis on the transplant waiting list in an attempt to attain local control of tumor and prevent progression Robert Goldstein, MD, personal communication, April 2000

Radio Frequency Ablation Contraindications: –Child ’ C cirrhosis (gross ascites) –Excessive tumor burden –Extrahepatic diseases –Active infection –Renal insufficiency –Coagulopathy –Near major ductal confluence

Radio Frequency Ablation Complications (0-12%): Complications (0-12%): ● Abscess formation ● Bleeding(delayed bleeding into the ablated area, subcutaneous/ subcapsular haematoma) ● Needle tract seeding (up to 12.5%) ● Bile leakage ● Bile duct stricture ● hydropneumothrorax ● Liver failure ● Grounding pad burn ● Acute renal failure ● Mortality: 0 -1%

Radio Frequency Ablation RFA may be a superior option amount the locoreginal ablation therapy: RFA may be a superior option amount the locoreginal ablation therapy: Lower complication rate Less recurrence rate Shorter hospital stay R Poon et la, Annals of Surgery 1999

Radio Frequency Ablation Question to answer What determine the efficacy of RFA in liver tumor patient ? What determine the efficacy of RFA in liver tumor patient ? Local Recurrence is one of the important aspects Local Recurrence is one of the important aspects Local recurrence was defined as radiological (CT, MRI or contrast-enhanced ultrasound) and/or histological (tumor cells with intact mitochondrial enzyme staining) detection of residual or recurrent viable tumor at the site of the original tumor, during follow-up and after completion of all (one or more) sessions.

Pre OT Post OT 1 week Post OT 3 months Siperstein A et la, Annals of Surgical Oncology 2005

Local Recurrence After Hepatic Radiofrequency Coagulation Multivariate Meta-Analysis and Review of Contributing Factors Stefaan Mulier, MD, Yicheng Ni, PhD, Jacques Jamart, MD,Theo Ruers, PhD, Guy Marchal, PhD, and Luc Michel, MD Annals of Surgery, August 2005

Local Recurrence Local recurrence rate after RFA of liver tumors varies widely between 2% and 60% Local recurrence rate after RFA of liver tumors varies widely between 2% and 60% A local recurrence seriously jeopardizes the chances of cure A local recurrence seriously jeopardizes the chances of cure Re-treatment is often impossible or has a high risk of failure Re-treatment is often impossible or has a high risk of failure From Solbiati L et al 1999, only 55% recurrent tumors were re-treated and a complete coagulation was obtained in only cases 36%. From Solbiati L et al 1999, only 55% recurrent tumors were re-treated and a complete coagulation was obtained in only cases 36%. Reasons for not considering re-treatment: Reasons for not considering re-treatment: unfavorable geometry diffuse metastases

Local Recurrence Rate: Univariable Analysis of Contributing Factors 9 factors: 9 factors: Diameter (size) Pathology Proximity of major vessel Location Approach (surgery Vs percutaneous) Intentional Margin Vascular occlusion AnaethesiaImaging Physician ’ s experience

Diameter (Size) Current recommended tumor size <5cm Current recommended tumor size <5cm Nearly all authors agree tumor size determining local recurrence /efficacy Nearly all authors agree tumor size determining local recurrence /efficacy Goletti O et al, Montorsi M et al, Livraghi T et al, showed that complete tumor necrosis in 80% to 90% of HCCs smaller than 3 to 5 cm Goletti O et al, Montorsi M et al, Livraghi T et al, showed that complete tumor necrosis in 80% to 90% of HCCs smaller than 3 to 5 cm Livraghi T et al, complete ablation rate for larger tumors is less favorable: a study of RFA for 126 HCCs 3.1 to 9.5 cm (mean 5.4 cm) reported a complete necrosis rate of 48% with the use of a clustered electrode. Livraghi T et al, complete ablation rate for larger tumors is less favorable: a study of RFA for 126 HCCs 3.1 to 9.5 cm (mean 5.4 cm) reported a complete necrosis rate of 48% with the use of a clustered electrode.

Diameter (Size) Size of individual RFA is limited Single coagulation cannot cover a large lesion i.e.< 100% necrosis – higher risk of local recurrence Single coagulation cannot cover a large lesion i.e.< 100% necrosis – higher risk of local recurrence Adam R et la, Arch Surg 2002 For large tumors, overlapping coagulations is necessary, however, technically difficulty – Ultrasonogram is difficult to visualize the tumor after 1st coagulation – hyperechoeic microbubble cloud For large tumors, overlapping coagulations is necessary, however, technically difficulty – Ultrasonogram is difficult to visualize the tumor after 1st coagulation – hyperechoeic microbubble cloud R Poon et la, Annals of Surgery 2000

Diameter (Size) Large tumors have irregular borders and present satellite lesions Livraghi T et la, Radiology 2000 If the coagulation is restricted to the main tumor without safety margin, spiky irregular extensions and satellites will be left untreated. If the coagulation is restricted to the main tumor without safety margin, spiky irregular extensions and satellites will be left untreated.

Effect of Tumor Size on Outcome of RF Ablation Tumors 100% Necrosis <100% Necrosis p value cm 49(61%)31(39%).001 >5cm11(24%)35(76%) Livraghi T et al. Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions. Radiology 2000; 214:761–768.

Diameter (Size) Conclusion There is no consensus for the optimal size for RFA There is no consensus for the optimal size for RFA Smaller tumor size ( < 3 cm diameter ), the better the outcome, the lesser the local recurrance rate Smaller tumor size ( < 3 cm diameter ), the better the outcome, the lesser the local recurrance rate Due the advancing technology, future electrode may tackle with larger tumor Due the advancing technology, future electrode may tackle with larger tumor

Approach Surgical (open / laparoscopic) Vs Percutaneous Surgical (open / laparoscopic) Vs Percutaneous Absence of RCT Absence of RCT No consensus No consensus

Surgical (open / laparoscopic) Vs Percutaneous From Steven A. Curley et la, complete ablations in the 65 HCCs treated during laparotomy or laparoscopy, however, 7.1% (6/84) incidence of incomplete RFA in the HCCs treated percutaneously. From Steven A. Curley et la, complete ablations in the 65 HCCs treated during laparotomy or laparoscopy, however, 7.1% (6/84) incidence of incomplete RFA in the HCCs treated percutaneously. From Rhim H et al, incomplete tumor destruction has been reported in up to 18% of liver cancers treated percutaneously with RFA From Rhim H et al, incomplete tumor destruction has been reported in up to 18% of liver cancers treated percutaneously with RFA

Surgical (open / laparoscopic) Vs Percutaneous One disadvantage to RFA is the difficulty in determine accurately the exact area that has been coagulated One disadvantage to RFA is the difficulty in determine accurately the exact area that has been coagulated Intraoperative or laparoscopic ultrasonography provides better resolution of the tumor and RFA treatment compared with transabdominal ultrasonography for percutaneous treatment Intraoperative or laparoscopic ultrasonography provides better resolution of the tumor and RFA treatment compared with transabdominal ultrasonography for percutaneous treatment Steven A. Curley et la, Annals of Surgery 2000

Surgical (open / laparoscopic) Vs Percutaneous Better tumor visualization compared with external ultrasound especially of tumors located in the superior right lobe of the liver Better tumor visualization compared with external ultrasound especially of tumors located in the superior right lobe of the liver ~30% increase in tumor detection rate by intraoperative ultrasound during laparoscopy or laparotomy compared with preoperative imaging ~30% increase in tumor detection rate by intraoperative ultrasound during laparoscopy or laparotomy compared with preoperative imaging Siperstein T et la, Annals of Surgical Oncology 2002 Siperstein T et la, Annals of Surgical Oncology 2002 Accurate tumor staging Accurate tumor staging K K-C Ng et la, Journal of Gastro-Hepatology 2003

Surgical (open / laparoscopic) Vs Percutaneous Easy access to tumors located in the superior right lobe of the liver Easy access to tumors located in the superior right lobe of the liver Improved visibility will lead to a more correct insertion of the electrodes and an increased chance of complete covering of the tumor, including its irregular margins, satellites, and a 1- cm safety margin Improved visibility will lead to a more correct insertion of the electrodes and an increased chance of complete covering of the tumor, including its irregular margins, satellites, and a 1- cm safety margin Mobilization of the liver allows larger degree of freedom for inserting the electrodes under an optimal angle Mobilization of the liver allows larger degree of freedom for inserting the electrodes under an optimal angle Rossi S et la, AJR AM J Roent-genol Rossi S et la, AJR AM J Roent-genol. 1996

Surgical (open / laparoscopic) Vs Percutaneous Laparoscopic approach, pneumoperitoneum and the upward movement of the diaphragm, liver movement is minimal, facilitating precise electrode placement. Laparoscopic approach, pneumoperitoneum and the upward movement of the diaphragm, liver movement is minimal, facilitating precise electrode placement. Siperstein A et la, Surgical Endoscopy 2002 Surgical route, allows multiple parallel reinsertions of the electrode when overlapping coagulations are necessary Surgical route, allows multiple parallel reinsertions of the electrode when overlapping coagulations are necessary Rossi S et la, AJR AM J Roent-genol. 1996

Surgical (open / laparoscopic) Vs Percutaneous Intraoperative RFA allows the use of Pringle maneuver to minimize the “ heat sink ” effect of the hepatic vessels Intraoperative RFA allows the use of Pringle maneuver to minimize the “ heat sink ” effect of the hepatic vessels Mulier S et la, Eur J Surgical Oncology 2003 During laparoscopy, a 12-mm Hg pneumoperitoneum by itself causes a 40% decrease of portal vein flow During laparoscopy, a 12-mm Hg pneumoperitoneum by itself causes a 40% decrease of portal vein flow Smith MK et la, Surgical Endoscopy 2004

A 5-cm hepatocellular carcinoma at the dome of the liver (A,arrow) treated by intraoperative radiofrequency ablation using a clustered probe (B). R Poon et la, Annals of Surgery 2002

Intraoperative ultrasound provides guidance to positioning of the probe (C, arrow shows the tip of the probe) in the tumor before starting radiofrequency ablation, but the exact margin of ablation is obscured by hyperechoic shadow resulting from thermal changes in the tissue after starting the ablation (D, arrows). R Poon et la, Annals of Surgery 2002

Surgical (open / laparoscopic) Vs Percutaneous Intended safety margin of 1 cm, was used much less in the percutaneous approach than in the surgical approach Intended safety margin of 1 cm, was used much less in the percutaneous approach than in the surgical approach Subcapsular tumors are often undertreated by a percutaneous approach because of fear of burning adjacent organs, diaphragm, or the abdominal wall Subcapsular tumors are often undertreated by a percutaneous approach because of fear of burning adjacent organs, diaphragm, or the abdominal wall R Poon et la, Annals of Surgery 2002

Surgical (open / laparoscopic) Vs Percutaneous Approach No. of Cases No Margin 0.5 cm Margin 1 cm Margin p Percutaneous %(2692)5.4%(165)6.2%(189)<0.001 Surgical %(360)13.6%(170)57.55%(718)<0.001 Intentional Margin According to Approach tumor 10 mm Ablation zone

Surgical (open / laparoscopic) Vs Percutaneous Conclusion Laparoscopic or open approach is recommended in patients with a high risk of bleeding from severe coagulopathy, large HCCs (5 cm), superficial nodules adjacent to other visceral organs at risk of thermal injury, or deeply located lesions not accessible to percutaneous puncture Laparoscopic or open approach is recommended in patients with a high risk of bleeding from severe coagulopathy, large HCCs (5 cm), superficial nodules adjacent to other visceral organs at risk of thermal injury, or deeply located lesions not accessible to percutaneous puncture R Poon et la, Annals of Surgery 2002

Surgical (open / laparoscopic) Vs Percutaneous The percutaneous route remains valuable for certain indications: The percutaneous route remains valuable for certain indications: For patients that are too fragile to undergo laparoscopy or laparotomy. Tumors that are invisible on ultrasound imaging can be treated by a CT- or MRI- guided percutaneous procedure. May be performed as a day procedure

Surgical (open / laparoscopic) Vs Percutaneous >5 cm cm <3 cm Laparoscopy/ Laparotomy (%) Percuteneous (%) Local Recurrence Rate According to Size and Approach

Conclusion Surgery remain the gold standard of treating liver tumor Surgery remain the gold standard of treating liver tumor RFA is superior option in treating unresectable primary and secondary RFA is superior option in treating unresectable primary and secondary Surgical approach have less local recurrance rate and better outcome when compared with percutaneous route Surgical approach have less local recurrance rate and better outcome when compared with percutaneous route Small size tumor have better outcome, however, advance technology may overcome this problem in future Small size tumor have better outcome, however, advance technology may overcome this problem in future

RFA Vs Cryoablation Local recurrence rate: Local recurrence rate: 2.2% Vs 13.6% 2.2% Vs 13.6% Treatment mortality: Treatment mortality: 0% Vs 2% 0% Vs 2% Complication rate: Complication rate: 3.3% Vs 40% 3.3% Vs 40% Pearson AS et al. Am. J. Surg. 1999

RFA Vs Microwave Coagulation Therapy Complete ablation: Complete ablation: 91% Vs 85% 91% Vs 85% Local recurrence Local recurrence 4%Vs 17% 4%Vs 17% Lencioni et al. Radiology 1999

RFA Vs PEI Complete necrosis : Complete necrosis : RFA Vs PEI – 90% Vs 80% RFA Vs PEI – 90% Vs 80% Treatment section: Treatment section: Mean 1.2 Vs 4.8 sessions Mean 1.2 Vs 4.8 sessions Complication rate: Complication rate: 12% Vs 0% 12% Vs 0% Livraghi T et al. Radiology 1999

RFA Vs TACE Complete control of tumor growth: Complete control of tumor growth: 50% Vs 30% 50% Vs 30% Mortality: Mortality: 0% Vs 4% 0% Vs 4% Livraghi et al. Radiology 2002

RFA Vs Resection Recurrence Recurrence 53% Vs 30% 53% Vs 30% Resection recurrence – distant recurrence Resection recurrence – distant recurrence RFA recurrence – local recurrence RFA recurrence – local recurrence Montorsi M et la, The Society for Surgery of the Alimentary Tract 2005 Resection is more effective, in terms of overall and disease-free survival, in Child ’ s A patient with a single tumour >3cm Resection is more effective, in terms of overall and disease-free survival, in Child ’ s A patient with a single tumour >3cm Vivarelli M et la, Annals of Surgery 2004 Vivarelli M et la, Annals of Surgery 2004

RFA – Bridge therapy Retrospective studyRetrospective study 14 cirrhotic patients with small HCC (  3.5cm)14 cirrhotic patients with small HCC (  3.5cm) RFA prior to transplanatationRFA prior to transplanatation Median follow-up: 16 monthsMedian follow-up: 16 months Histology :Histology : – complete necrosis: 71% – incomplete necrosis: 29% – tumour satellites < 1cm from main tumour: 57% No complication/ death/ recurrenceNo complication/ death/ recurrence